These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3856722)
1. [The effect of cytostatic therapy on pyruvate kinase activity in the erythrocytes of patients with acute myelocytic leukemia]. Labar B; Jusufhodzić L Lijec Vjesn; 1985 Feb; 107(2):61-3. PubMed ID: 3856722 [No Abstract] [Full Text] [Related]
2. [Possibilities for the cure of acute myeloblastic leukemia with the modified VAPA regimen: preliminary results]. Díaz Mediavilla J; del Potro Gómez E; Llorente Pérez L; Martínez Martínez R; Guerra Moyano JL; de la Vega Bueno E; Alvarez Carmona A; Krsnik Castelló I; Alarcón Zurita C; Rodríguez Vázquez M Med Clin (Barc); 1984 Dec; 83(19):783-6. PubMed ID: 6597329 [No Abstract] [Full Text] [Related]
3. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia]. Paśnicki M Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239 [No Abstract] [Full Text] [Related]
4. Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols. Khattab TM; Atra AA; Elimam NA; Kassar A; Zayed A; Baothman A Saudi Med J; 2008 May; 29(5):776-7. PubMed ID: 18454233 [No Abstract] [Full Text] [Related]
5. Long term results in acute non-lymphocytic leukaemia. Saikia TK; Rajni A; Gopal R; Nair CN; Nadkarni KS; Kurkure PA; Pai VR; Pai SK; Advani SH J Assoc Physicians India; 1988 Aug; 36(8):505-7. PubMed ID: 3073153 [No Abstract] [Full Text] [Related]
6. Acute myeloid leukemia in adults: experience at AIIMS. Raina V; Kochupillai V J Assoc Physicians India; 1983 Aug; 31(8):511-4. PubMed ID: 6581155 [No Abstract] [Full Text] [Related]
7. Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia. Willemze R; Fibbe WE; Zwaan FE Neth J Med; 1983; 26(8):215-9. PubMed ID: 6580554 [No Abstract] [Full Text] [Related]
8. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia. Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502 [No Abstract] [Full Text] [Related]
9. [Deficiency in erythrocytic pyruvate-kinase during acute leukemia]. Najman A; Leroux JP; Temkine H; Cartier P; André R Rev Fr Etud Clin Biol; 1969 Oct; 14(8):795-6. PubMed ID: 5263551 [No Abstract] [Full Text] [Related]
10. Chemotherapy of acute myeloblastic leukaemia with DAM regimen. Yunus AB; Sayeed MA; Barua A; Rahman J; Rashid MA Bangladesh Med Res Counc Bull; 1997 Dec; 23(3):82-6. PubMed ID: 9621477 [TBL] [Abstract][Full Text] [Related]
12. [Results of treatment with 2 chemotherapeutic protocols (TAPA and VAPA) in acute myeloblastic leukemia]. Avilés-Miranda A; Ambriz-Fernández R; García-Vela E; Monroy-Arellano L; Pizzuto J Gac Med Mex; 1984 Apr; 120(4):145-50. PubMed ID: 6593266 [No Abstract] [Full Text] [Related]
13. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine. Sitar DS; Aoki FY; Bow EJ J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946 [No Abstract] [Full Text] [Related]
14. [Erythrocyte metabolism in patients with acute leukemia and a deficiency of the enzyme pyruvate kinase]. Labar B; Stavljenić A; Jusufhodzić L Lijec Vjesn; 1984; 106(11-12):447-51. PubMed ID: 6596474 [No Abstract] [Full Text] [Related]
15. [Glucose-6-phosphate dehydrogenase and pyruvate kinase activity and the content of adenosine triphosphate in the erythrocytes of leukemic patients]. Gekova K; Arsov Ts; Georgieva B Vutr Boles; 1979; 18(4):74-8. PubMed ID: 291225 [TBL] [Abstract][Full Text] [Related]
16. [HOAP/HOAGP in the treatment of acute non-lymphocytic leukemia: an analysis of 68 cases]. Shan YD Zhonghua Yi Xue Za Zhi; 1985 Oct; 65(10):590-2. PubMed ID: 3938671 [No Abstract] [Full Text] [Related]
17. Treatment of blast crisis of chronic myelogenous leukemia with vincristine, prednisone, and cytarabine. Cervantes F; Rozman C; Bladé J; Montserrat E; Grañena A Cancer Treat Rep; 1985; 69(7-8):923-4. PubMed ID: 3860299 [No Abstract] [Full Text] [Related]
18. Fetal liver infusion: an adjuvant in the therapy of acute myeloid leukemia (AML). Kochupillai V; Sharma S; Francis S; Mehra NK; Nanu A; Verma IC; Takkar D; Kumar S; Gokhale U Prog Clin Biol Res; 1985; 193():267-79. PubMed ID: 3911212 [No Abstract] [Full Text] [Related]
19. Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome. Estey EH; Kantarjian H; Keating M Semin Oncol; 1993 Dec; 20(6 Suppl 8):1-5. PubMed ID: 8290966 [TBL] [Abstract][Full Text] [Related]
20. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors. Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]